PMID- 26931618 OWN - NLM STAT- MEDLINE DCOM- 20170327 LR - 20170915 IS - 1096-1186 (Electronic) IS - 1043-6618 (Linking) VI - 107 DP - 2016 May TI - Sniping the scout: Targeting the key molecules in dendritic cell functions for treatment of autoimmune diseases. PG - 27-41 LID - S1043-6618(16)30096-2 [pii] LID - 10.1016/j.phrs.2016.02.023 [doi] AB - Dendritic cells (DCs) are a power tool for manipulating immune system. They play important roles in the induction of immunity as well as inducing intrathymic and peripheral tolerance. After generated from stem cells in the bone marrow, DCs traffic to the peripheral tissues, where they capture and process antigens, express lymphocyte co-stimulators, migrate to the secondary lymph organs and present the processed antigen to naive T cells to either activate or tolerize them. These processes are modulated subtly and influenced by various factors. Aberrant regulation of the processes may cause autoimmunity. Investigation into the biology of DCs and the molecules and mechanisms that regulate them helps us understanding the pathogenesis of autoimmune diseases and reveals numerous steps for pharmacological manipulation. In this review, we made a sketch line of the critical events of DC biology that are potential pharmacologic targets for the treatment of autoimmune diseases. CI - Copyright (c) 2016 Elsevier Ltd. All rights reserved. FAU - Li, Xing AU - Li X AD - Department of Rheumatology and Immunology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China; Institute of Clinical Immunology, Academy of Orthopedics, Guangdong Province, China. FAU - Han, Yanping AU - Han Y AD - Hospital of South China Normal University, Guangzhou, China. FAU - Sun, Erwei AU - Sun E AD - Department of Rheumatology and Immunology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China; Institute of Clinical Immunology, Academy of Orthopedics, Guangdong Province, China. Electronic address: sunew@smu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20160227 PL - Netherlands TA - Pharmacol Res JT - Pharmacological research JID - 8907422 SB - IM MH - Animals MH - Autoimmune Diseases/*immunology MH - Autoimmunity MH - Dendritic Cells/*immunology MH - Humans OTO - NOTNLM OT - Apigenin (PubChem CID: 5280443) OT - Aspirin (PubChem CID: 2244) OT - Auranofin (PubChem CID: 24199313) OT - Autoimmune diseases OT - Butyric acid (PubChem CID: 264) OT - Chloroquine (PubChem CID: 2719) OT - Chrysin (PubChem CID: 5281607) OT - Cyclosporin a (PubChem CID: 5284373) OT - Dendritic cells OT - Dexamethasone (PubChem CID: 5743) OT - FTY720 (PubChem CID: 107969) OT - Fostamatinib (PubChem CID: 11671467) OT - Fumarates (PubChem CID: 5281069) OT - Glatiramer acetate (PubChem CID: 3081884) OT - IL-10 (PubChem CID: 146070) OT - Leflunomide (PubChem CID: 3899) OT - Mycophenolate mofetil (PubChem CID: 5281078) OT - N-acetyl-L-cysteine (PubChem CID: 12035) OT - Oenothein B (PubChem CID: 16132398) OT - Quercetin (PubChem CID: 5280343) OT - Rapamycin (PubChem CID: 5284616) OT - Rheumatoid arthritis OT - Rosiglitazone (PubChem CID: 77999) OT - Sanglifehrin a (PubChem CID: 5388925) OT - Sunitinib (PubChem CID: 5329102) OT - Systemic lupus erythematosus OT - T helper OT - TGF-beta (PubChem CID: 56842206) OT - Tacrolimus (PubChem CID: 445643) OT - Tofacitinib (PubChem CID: 9926791) OT - Trichostatin A (PubChem CID: 444732) OT - Triptolide (PubChem CID: 107985) OT - Troglitazone (PubChem CID: 5591) OT - Vasoactive intestinal peptide (PubChem CID: 16129679) OT - Vitamin D3 (PubChem CID: 5280795) EDAT- 2016/03/05 06:00 MHDA- 2017/03/28 06:00 CRDT- 2016/03/03 06:00 PHST- 2016/02/05 00:00 [received] PHST- 2016/02/23 00:00 [revised] PHST- 2016/02/23 00:00 [accepted] PHST- 2016/03/03 06:00 [entrez] PHST- 2016/03/05 06:00 [pubmed] PHST- 2017/03/28 06:00 [medline] AID - S1043-6618(16)30096-2 [pii] AID - 10.1016/j.phrs.2016.02.023 [doi] PST - ppublish SO - Pharmacol Res. 2016 May;107:27-41. doi: 10.1016/j.phrs.2016.02.023. Epub 2016 Feb 27.